Guillain-Barré Syndrome in COVID-19: A Probable Association

Guillain–Barré syndrome (GBS) is characterized by areflexia, albuminocytologic dissociation and progressive motor weakness. It has been associated with preceding viral infections. We report a case suggestive of a possible link between GBS and prior COVID-19 infection. A 20-year-old female from Dhankuta, with a history of COVID-19 infection diagnosed one month earlier, presented to the emergency department at B.P. Koirala Institute of Health Sciences (BPKIHS) with a two-day history of ascending paralysis. Based on the Brighton Criteria, a clinical diagnosis of GBS was suspected. In the context of the COVID-19 pandemic, GBS associated with SARS-CoV-2 infection should be carefully differentiated from other causes of neuropathy and myopathy. A high index of suspicion is essential for timely diagnosis and management.